The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
The prevalence package provides Frequentist and Bayesian methods for prevalence assessment studies. IMPORTANT: the truePrev functions in the prevalence package call on JAGS (Just Another Gibbs Sampler), which therefore has to be available on the user's system. JAGS can be downloaded from <https://mcmc-jags.sourceforge.io/>.
Version: | 0.4.1 |
Depends: | R (≥ 4.0.0) |
Imports: | methods, utils, stats, graphics, grDevices, coda, rjags |
Published: | 2022-06-03 |
DOI: | 10.32614/CRAN.package.prevalence |
Author: | Brecht Devleesschauwer [aut, cre], Paul Torgerson [aut], Johannes Charlier [aut], Bruno Levecke [aut], Nicolas Praet [aut], Sophie Roelandt [aut], Suzanne Smit [aut], Pierre Dorny [aut], Dirk Berkvens [aut], Niko Speybroeck [aut] |
Maintainer: | Brecht Devleesschauwer <brechtdv at gmail.com> |
BugReports: | https://github.com/brechtdv/prevalence/issues |
License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
URL: | http://prevalence.cbra.be/ |
NeedsCompilation: | no |
SystemRequirements: | JAGS (>= 4.0.0) (see https://mcmc-jags.sourceforge.io/) |
Citation: | prevalence citation info |
Materials: | README NEWS |
In views: | Bayesian |
CRAN checks: | prevalence results |
Reference manual: | prevalence.pdf |
Package source: | prevalence_0.4.1.tar.gz |
Windows binaries: | r-devel: prevalence_0.4.1.zip, r-release: prevalence_0.4.1.zip, r-oldrel: prevalence_0.4.1.zip |
macOS binaries: | r-release (arm64): prevalence_0.4.1.tgz, r-oldrel (arm64): prevalence_0.4.1.tgz, r-release (x86_64): prevalence_0.4.1.tgz, r-oldrel (x86_64): prevalence_0.4.1.tgz |
Old sources: | prevalence archive |
Please use the canonical form https://CRAN.R-project.org/package=prevalence to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.